Glutaminolysis and peripheral CD4+ T cell differentiation: from mechanism to intervention strategy
暂无分享,去创建一个
[1] K. Park,et al. Targeting glutamine metabolism as a therapeutic strategy for cancer , 2023, Experimental & molecular medicine.
[2] S. Abrignani,et al. Human T lymphocytes at tumor sites , 2022, Seminars in Immunopathology.
[3] Ying Shen,et al. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. , 2022, Cancer research.
[4] G. Wang,et al. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice. , 2022, International immunopharmacology.
[5] G. K. Khurana Hershey,et al. The role of the CBM complex in allergic inflammation and disease. , 2022, The Journal of allergy and clinical immunology.
[6] R. Cianciolo,et al. Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL‐17A , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] V. Kuchroo,et al. B Cell IL-4 Drives Th2 Responses In Vivo, Ameliorates Allograft Rejection, and Promotes Allergic Airway Disease , 2022, Frontiers in Immunology.
[8] L. Fong,et al. Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox , 2021, Immunity.
[9] Ping-Chih Ho,et al. Fueling T-cell Antitumor Immunity: Amino Acid Metabolism Revisited , 2021, Cancer Immunology Research.
[10] B. Skålhegg,et al. Identification and characterization of a novel glutaminase inhibitor , 2021, FEBS open bio.
[11] S. Im,et al. Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation , 2021, Allergy.
[12] Yana Geng,et al. Bergenin, a PPARγ agonist, inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysis , 2021, Acta Pharmacologica Sinica.
[13] D. Krappmann,et al. A patent review of MALT1 inhibitors (2013-present) , 2021, Expert opinion on therapeutic patents.
[14] Yun Zheng,et al. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists , 2021, Theranostics.
[15] M. Kopf,et al. Redox regulation of immunometabolism , 2020, Nature Reviews Immunology.
[16] Wei-Chen Lee,et al. Targeting glutamine metabolism as an effective means to promote allograft acceptance while inhibit tumor growth. , 2020, Transplant immunology.
[17] Ya Chun Yu,et al. Glutamine reliance in cell metabolism , 2020, Experimental & Molecular Medicine.
[18] S. Bröer. Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How , 2020, International journal of molecular sciences.
[19] W. Zhou,et al. GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis. , 2020, The Journal of clinical investigation.
[20] Zhuo-wei Hu,et al. PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia , 2020, Theranostics.
[21] W. Ren,et al. Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases , 2020, Science China Life Sciences.
[22] Hong Jin,et al. T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus , 2020, Frontiers in Immunology.
[23] Peng Wang,et al. The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4+ T Cell Subsets , 2020, Journal of immunology research.
[24] Nicole M. Chapman,et al. mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions , 2020, Immunological reviews.
[25] Delong Meng,et al. Glutamine and asparagine activate mTORC1 independently of Rag GTPases , 2020, The Journal of Biological Chemistry.
[26] Ligong Chen,et al. Solute carrier transporters: the metabolic gatekeepers of immune cells , 2019, Acta pharmaceutica Sinica. B.
[27] H. Lee,et al. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. , 2019, Cell metabolism.
[28] Linda V. Sinclair,et al. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation , 2019, bioRxiv.
[29] T. Masuko,et al. Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells , 2019, Cancer medicine.
[30] G. Tsokos,et al. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus‐like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis , 2019, Arthritis & rheumatology.
[31] Graham M. West,et al. Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation , 2019, eLife.
[32] R. Beyaert,et al. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells. , 2019, Cellular immunology.
[33] Jingwei Jiang,et al. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[34] S. Gupta,et al. Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach , 2019, Metabolites.
[35] Yuquan Wei,et al. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization , 2019, Cell Death & Disease.
[36] Shaohe Wang,et al. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway , 2018, EBioMedicine.
[37] J. Locasale,et al. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism , 2018, Cell.
[38] J. Mellor,et al. IDH1: Linking Metabolism and Epigenetics , 2018, Front. Genet..
[39] Lei Gao,et al. c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer. , 2018, Biochemical and biophysical research communications.
[40] Tingting Wang,et al. Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation , 2018, eLife.
[41] Y. Li,et al. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition , 2018, BMB reports.
[42] A. Bröer,et al. Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets , 2018, Front. Pharmacol..
[43] L. Quek,et al. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways , 2018, BMC Cancer.
[44] E. Pearce,et al. Unraveling the Complex Interplay Between T Cell Metabolism and Function. , 2018, Annual review of immunology.
[45] K. Maloy,et al. Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease , 2018, Front. Immunol..
[46] G. Tsokos,et al. Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells , 2018, Proceedings of the National Academy of Sciences.
[47] D. Farber,et al. Human T Cell Development, Localization, and Function throughout Life. , 2018, Immunity.
[48] Wenyan Ren,et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma , 2018, Cell Death & Differentiation.
[49] William P. Katt,et al. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism , 2018, The Journal of Biological Chemistry.
[50] S. Gygi,et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway , 2017, Science.
[51] U. Staubli,et al. Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slices , 2017, Neuropharmacology.
[52] Frédérick A. Mallette,et al. Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling. , 2017, Trends in cell biology.
[53] Y. Zhang,et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism , 2017, Nature.
[54] G. Qing,et al. Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism , 2017, Oncogenesis.
[55] S. Venneti,et al. Glutaminolysis: A Hallmark of Cancer Metabolism. , 2017, Annual review of biomedical engineering.
[56] Jiahuai Han,et al. 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter. , 2017, Cell reports.
[57] M. Bianchi,et al. GPNA inhibits the sodium-independent transport system l for neutral amino acids , 2017, Amino Acids.
[58] J. Powell,et al. mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation , 2017, The Journal of Immunology.
[59] T. Mak,et al. Glutathione Primes T Cell Metabolism for Inflammation , 2017, Immunity.
[60] Ming Zhou,et al. Interplay between Immune Checkpoint Proteins and Cellular Metabolism. , 2017, Cancer research.
[61] H. Ando,et al. Establishment of monoclonal antibodies against cell surface domains of ASCT2/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth. , 2017, Biochemical and biophysical research communications.
[62] M. Magnani,et al. Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics , 2016, Journal of Virology.
[63] S. Bröer,et al. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells* , 2016, The Journal of Biological Chemistry.
[64] William P. Katt,et al. Design and evaluation of novel glutaminase inhibitors. , 2016, Bioorganic & medicinal chemistry.
[65] M. Boothby. Faculty Opinions recommendation of Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. , 2016 .
[66] S. Kaech,et al. The multifaceted role of CD4+ T cells in CD8+ T cell memory , 2016, Nature Reviews Immunology.
[67] Liqing Zhou,et al. fMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma , 2015, PLoS genetics.
[68] Shao-Cong Sun,et al. TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex. , 2015, Molecular immunology.
[69] Philippe A. Robert,et al. Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation , 2015, Science Signaling.
[70] Jeffrey W. Smith,et al. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. , 2015, Cancer cell.
[71] K. Guan,et al. Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.
[72] R. Deberardinis,et al. Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells , 2014, Proceedings of the National Academy of Sciences.
[73] Jae-Hoon Chang,et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. , 2014, Immunity.
[74] K. Thangavelu,et al. Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA) , 2014, Scientific Reports.
[75] B. Ross,et al. Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus , 2013, Epilepsy Research.
[76] A. Simeonov,et al. Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors. , 2013, Biochemical and biophysical research communications.
[77] M. Leuenberger,et al. The SLC1 high-affinity glutamate and neutral amino acid transporter family. , 2013, Molecular aspects of medicine.
[78] A. Lane,et al. Control of Glutamine Metabolism By the Tumor Suppressor Rb , 2013, Oncogene.
[79] P. Koutentis,et al. Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. , 2012, Toxicology and applied pharmacology.
[80] R. Gill,et al. CD4 T cells mediate cardiac xenograft rejection via host MHC Class II. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[81] C. Akdis,et al. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. , 2012, The Journal of allergy and clinical immunology.
[82] A. Hirao,et al. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. , 2021, Cell reports.
[83] J. Sprent,et al. The role of interleukin-2 during homeostasis and activation of the immune system , 2012, Nature Reviews Immunology.
[84] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[85] A. Palamara,et al. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules. , 2011, Vaccine.
[86] G. Semenza,et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.
[87] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[88] P. Worley,et al. The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.
[89] S. Crotty,et al. Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.
[90] M. Magnani,et al. The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice. , 2010, Vaccine.
[91] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.
[92] K. Frauwirth,et al. Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.
[93] A. Bado,et al. Luminal leptin inhibits L-glutamine transport in rat small intestine: involvement of ASCT2 and B0AT1. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[94] W. Langdon,et al. Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1 , 2009, Proceedings of the National Academy of Sciences.
[95] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[96] Shelly C. Lu. Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.
[97] N. Curthoys,et al. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES). , 2007, The Biochemical journal.
[98] A. Israël,et al. Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of Bcl10 , 2007, Proceedings of the National Academy of Sciences.
[99] C. Esslinger,et al. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. , 2005, Bioorganic & medicinal chemistry.
[100] D. Schoetz. Who, Why, What, and How? , 2004, Diseases of the colon and rectum.
[101] C. Grewer,et al. New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+‐dependent anion leak , 2004, The Journal of physiology.
[102] J. Hamuro,et al. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. , 2002, International immunopharmacology.
[103] S. Low,et al. Mechanisms of Glutamine Transport in Rat Adipocytes and Acute Regulation by Cell Swelling , 2001, Cellular Physiology and Biochemistry.
[104] T. Ishii,et al. An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models. , 2018, American journal of cancer research.
[105] U. Khan,et al. T Lymphocytes and Autoimmunity. , 2018, International review of cell and molecular biology.
[106] B. Medoff,et al. The role of CARMA1 in T cells. , 2013, Critical reviews in immunology.
[107] A. Khoruts,et al. In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.